MW
VRTX icon

MBL Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

MBL Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
612
+55
+10% +$24.4K 0.02% 279
2026
Q1 		$249K Sell
557
-27
-5% -$12.6K 0.02% 284
2025
Q4 		$265K Buy
+584
New +$252K 0.02% 252
2025
Q3 		– Sell
-542
Closed -$241K – 260
2025
Q2 		$241K Sell
542
-11
-2% -$5.07K 0.02% 210
2025
Q1 		$268K Sell
553
-72
-12% -$33.6K 0.03% 188
2024
Q4 		$252K Sell
625
-79
-11% -$36.6K 0.03% 193
2024
Q3 		$327K Sell
704
-79
-10% -$37.9K 0.04% 158
2024
Q2 		$367K Sell
783
-105
-12% -$45.6K 0.04% 147
2024
Q1 		$371K Buy
+888
New +$375K 0.04% 142

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MBL Wealth's VRTX Position: Q2 2026 in Review

MBL Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q2 2026, buying an estimated $24.4K and bringing the position to 612 shares worth $304K. The position accounts for 0.02% of the portfolio, ranked #279.

MBL Wealth first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $371K in Q1 2024. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • MBL Wealth held 612 shares of Vertex Pharmaceuticals worth $304K as of Q2 2026.
  • MBL Wealth bought 55 Vertex Pharmaceuticals shares in Q2 2026, an estimated $24.4K.
  • Vertex Pharmaceuticals made up 0.02% of MBL Wealth's portfolio in Q2 2026, its #279 holding.
  • MBL Wealth first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • MBL Wealth's Vertex Pharmaceuticals position peaked at $371K in Q1 2024.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.